Common Contracts
1 similar Proposed Merger contracts
PROPOSED MERGERProposed Merger • July 29th, 2022
Caladrius Biosciences, Inc. (‘‘Caladrius’’) and Cend Therapeutics, Inc. (‘‘Cend’’) have entered into an Agreement and Plan of Merger and Reorganization (the ‘‘Merger Agreement’’) pursuant to which a wholly owned subsidiary of Caladrius will merge with and into Cend, with Cend surviving as a wholly owned subsidiary of Caladrius (the ‘‘Merger’’).
